Silo Pharma, Inc.
SILO
$0.7261
-$0.053-6.80%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 0.00% | |||
| Cost of Revenue | 0.00% | 0.00% | |||
| Gross Profit | 0.00% | 0.00% | |||
| SG&A Expenses | -31.49% | 48.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -39.28% | 78.13% | |||
| Operating Income | 39.67% | -79.53% | |||
| Income Before Tax | 40.40% | -86.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 40.40% | -86.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 40.40% | -86.33% | |||
| EBIT | 39.67% | -79.53% | |||
| EBITDA | 39.73% | -79.42% | |||
| EPS Basic | 40.32% | -78.51% | |||
| Normalized Basic EPS | 40.14% | -78.58% | |||
| EPS Diluted | 40.32% | -78.51% | |||
| Normalized Diluted EPS | 40.14% | -78.58% | |||
| Average Basic Shares Outstanding | -0.13% | 4.38% | |||
| Average Diluted Shares Outstanding | -0.13% | 4.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||